Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9784	Companies
196006	Keywords
127065	Articles
104238	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 04/09/2024 at 22:15, 1 year 9 months ago

Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
Jaguar Health, Inc. announces decision not to implement a reverse split at this time. Top line results for phase 3 OnTarget trial of crofelemer pending. Stockholders approve proposals at Special Meeting

Crofelemer Stockholders Meeting Jaguar Health Reverse Split Phase 3 Trial
BRIEF

published on 04/08/2024 at 14:35, 1 year 9 months ago

Jaguar Health Granted Extension to Regain Nasdaq Compliance, Announces OnTarget Trial Results Soon

Crofelemer Jaguar Health Nasdaq Compliance Cancer Therapy OnTarget Trial
BRIEF

published on 04/08/2024 at 14:35, 1 year 9 months ago

Jaguar Health obtient une prolongation pour rétablir la conformité au Nasdaq et annonce bientôt les résultats de l'essai OnTarget

Crofelemer Santé Jaguar Thérapie Contre Le Cancer Conformité Au Nasdaq Essai OnTarget
PRESS RELEASE

published on 04/08/2024 at 14:30, 1 year 9 months ago

Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
Jaguar Health, Inc. announces extended grace period from Nasdaq for bid price compliance. Top line results awaited for crofelemer's cancer therapy-related diarrhea prevention trial

Crofelemer Nasdaq Jaguar Health Cancer Therapy Grace Period
BRIEF

published on 04/02/2024 at 14:35, 1 year 10 months ago

Jaguar Health, Inc. Announces Appointment of European Pharmaceutical Industry Veteran as President of Jaguar International

Pharmaceutical Industry Crofelemer Jaguar Health Massimo Radaelli Commercial Expansion
BRIEF

published on 04/02/2024 at 14:35, 1 year 10 months ago

Jaguar Health, Inc. annonce la nomination d'un vétéran de l'industrie pharmaceutique européenne au poste de président de Jaguar International

Crofelemer Expansion Commerciale Industrie Pharmaceutique Santé Jaguar Massimo Radaelli
PRESS RELEASE

published on 04/02/2024 at 14:30, 1 year 10 months ago

Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Dr. Massimo Radaelli appointed as President of Jaguar International to expand commercial footprint globally with recent out-license agreement. Key pharmaceutical industry leader with vast experience and expertise

Pharmaceutical Industry Jaguar Health International Expansion Massimo Radaelli Out-license Agreement
BRIEF

published on 04/01/2024 at 14:05, 1 year 10 months ago

Jaguar Health Reports Financial Downturn in 2023 Results

Financial Results Revenue Decline Jaguar Health Mytesi Phase 3 Trial
BRIEF

published on 04/01/2024 at 14:05, 1 year 10 months ago

Jaguar Health annonce un ralentissement financier dans ses résultats 2023

Résultats Financiers Mytesi Baisse Des Revenus Santé Jaguar Essai De Phase 3
PRESS RELEASE

published on 04/01/2024 at 14:00, 1 year 10 months ago

Jaguar Health Reports 2023 Financial Results
Jaguar Health, Inc. reports an 18% decrease in net revenue for 2023 compared to 2022. Phase 3 OnTarget trial details and upcoming investor webcast disclosed

Financial Results Investor Webcast Jaguar Health Inc. Net Revenue Phase 3 OnTarget Trial

Accesswire

Published on 02/02/2026 at 23:55, 5 hours 15 minutes ago

2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 5 hours 15 minutes ago

55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 5 hours 45 minutes ago

Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 7 hours 5 minutes ago

Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 14 hours 10 minutes ago

Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform

View all ACCESSWIRE

EQS Group

Published on 02/02/2026 at 20:00, 9 hours 10 minutes ago

CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy
Published on 02/02/2026 at 19:57, 9 hours 13 minutes ago

US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 9 hours 27 minutes ago

EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 10 hours 5 minutes ago

Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 19:00, 10 hours 10 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

Les Echos

Published on 02/02/2026 at 18:23, 10 hours 47 minutes ago

Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:23, 10 hours 47 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026
Published on 02/02/2026 at 18:00, 11 hours 10 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 18:00, 11 hours 10 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 02/02/2026 at 18:00, 11 hours 10 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE